 |
| | | | | | |
|---|
 | 2017 |
| |
 | 01 |
| |
| 02 |
| |
| 03 |
| |
| 04 |
| |
| 05 |
| |
| 06 |
| |
| 07 |
| |
| 08 |
| |
| 09 |
| |
| 10 |
| |
| 11 |
| |
| 12 |
| |
| | 12/21/2017 | 07:00 PM | | FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma |  | |
| | 12/12/2017 | 10:00 AM | | Allan Gabor Takes Over the Leadership of Merck KGaA, Darmstadt, Germany, in China |  | |
| | 12/07/2017 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Receives Approval (Updated Registration) for Cladribine Tablets in Australia | | |
| | 12/06/2017 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, announces new head of its Semiconductor Materials business | | |
| 2018 |
| |
|